Cohen A, Ullman B, Martin DW Jr. Characterization of a mutant mouse lymphoma
cell with deficient transport of purine and pyrimidine nucleosides. J Biol Chem
1979;254:112–116.
Collnot EM, Baldes C, Wempe MF, Hyatt J, Navarro L, Edgar KJ, Schaefer UF, Lehr
CM. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux
transporters in Caco-2 cell monolayers. J Control Release 2006;111:35–40.
Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its
conjugates by the human organic anion transporter SLC21A6. J Biol Chem
2001;276:9626–9630.
Davit B, Reynolds K, Yuan R, Ajayi F, Conner D, Fadiran E, Gillespie B, Sahajwalla
C, Huang S-M, Lesko LJ. FDA evaluations usingin vitrometabolism to predict and
interpretin vivo metabolic drug–drug interactions: impact on labeling. J Clin
Pharmacol 1999;39:899–910.
Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer
2005;5:275–284.
Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. A
multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Nat
Acad Sci USA 1998;95:15665–15670.
Dresser GK, Kim RB, Bailey DG. Effect of grapefruit juice volume on the reduction of
fexofenadine bioavailability: possible role of organic anion transporting polypep-
tides. Clin Pharmacol Ther 2005;77:170–177.
Druekes P, Schinzel R, Palm D. Photometric microtiter assay of inorganic phosphate in
the presence of acid-labile organic phosphates. Anal Biochem 1995;230:173–177.
Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH,
Woster PM, Schuetz JD, Watkins P. 6^0 ,7^0 -Dihydroxybergamottin in grapefruit juice
and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and
P-glycoprotein. Clin Pharmacol Ther 1999;65:237–244.
Elferink RPJO, De Haan J, Lambert KJ, Hagey LR, Hofmann AF, Jansen PLM.
Selective hepatobiliary transport of nordeoxycholate side chain conjugates in mutant
rats with a canalicular transport defect. Hepatology (Philadelphia, PA, United
States) 1989;9:861–865.
Endres CJ, Hsiao P, Chung FS, Unadkat JD. The role of transporters in drug
interactions. Eur J Pharm Sci 2006;27:501–517.
Fedeli L, Colozza M, Boschetti E, Sabalich I, Aristei C, Guerciolini R, Del Favero A,
Rossetti R, Tonato M, Rambotti P, Davis S. Pharmacokinetics of vincristine in
cancer patients treated with nifedipine. Cancer 1989;64:1805–1811.
Fenster PE, Hager WD, Goodman MM. Digoxin–quinidine–spironolactone interac-
tion. Clin Pharmacol Ther 1984;36:70–73.
Floren LC, Bekersky I, Benet LZ, Mekki Q, Dressler D, Lee JW, Roberts JP, Hebert
MF. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole.
Clin Pharmacol Ther 1997;62:41–49.
Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a
multidrug-resistance gene in human tumors and tissues. Proc Nat Acad Sci USA
1987;84:265–269.
Forman B, Dussault I, Synold TW. Methods for altering SXR activation using peptide
mimetic HIV proteaseinhibitor SXR ligands to reduce drug resistance and drug
188 DRUG TRANSPORTERS IN DRUG DISPOSITION, DRUG INTERACTIONS